Location · Tampa, FL
Clinical trials in Tampa, FL
548 recruiting studies have a site in the Tampa area, and 80 of them accept healthy volunteers. The area includes St. Petersburg, Saint Petersburg, Clearwater, Brandon, Largo, Lakeland and nearby cities.
548 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 4
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Bausch Health Americas, Inc.
- Location
- Bryant, AR + 13 other US sites
- Eligibility basics
- Ages 9–11
- RecruitingPhase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
GlaxoSmithKline
- Location
- Newport Beach, CA + 37 other US sites
- Eligibility basics
- Ages 40–75
- RecruitingPhase 2
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
RAPT Therapeutics, Inc., a member of the GSK plc group of companies
- Location
- Phoenix, AZ + 21 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingPhase 2
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Kinaset Therapeutics Inc
- Location
- Lancaster, CA + 8 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
Minerva Neurosciences
- Location
- Bellflower, CA + 12 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Janssen Research & Development, LLC
- Location
- Paradise Valley, AZ + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Maze Therapeutics
- Location
- Decatur, AL + 58 other US sites
- Eligibility basics
- Ages 18–68
- RecruitingPhase 2
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Syndeio Biosciences, Inc
- Location
- Phoenix, AZ + 22 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingPhase 3
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Chandler, AZ + 62 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Axsome Therapeutics, Inc.
- Location
- Auburn, AL + 37 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Neurocrine Biosciences
- Location
- Huntsville, AL + 38 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Navigator Medicines, Inc.
- Location
- Phoenix, AZ + 13 other US sites
- Eligibility basics
- Ages 18–70
- Recruiting
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
Innova Vascular, Inc.
- Location
- Birmingham, AL + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
Takeda
- Location
- Redwood City, CA + 12 other US sites
- Eligibility basics
- Ages 18–70
- Recruiting
The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism
Thrombolex, Inc.
- Location
- Scottsdale, AZ + 22 other US sites
- Eligibility basics
- Any age listed
- Recruiting
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
Laminate Medical Technologies
- Location
- Long Beach, CA + 7 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Anthos Therapeutics, Inc.
- Location
- Birmingham, AL + 131 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 3
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
United Therapeutics
- Location
- Birmingham, AL + 73 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
Urotronic Inc.
- Location
- Little Rock, AR + 6 other US sites
- Eligibility basics
- Ages 50+ · Men only
- RecruitingPhase 1/Phase 2
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne
Sanofi Pasteur, a Sanofi Company
- Location
- Encino, CA + 3 other US sites
- Eligibility basics
- Ages 18–45
- RecruitingPhase 2
A Study of NTX-1472 in Social Anxiety Disorder
Newleos Therapeutics, Inc.
- Location
- Encino, CA + 9 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
LEO Pharma
- Location
- Birmingham, AL + 13 other US sites
- Eligibility basics
- Ages 6 mo–11
- RecruitingPhase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Eli Lilly and Company
- Location
- Birmingham, AL + 35 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Eli Lilly and Company
- Location
- Huntington Beach, CA + 41 other US sites
- Eligibility basics
- Ages 55+